Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 009 JPY -0.79% Market Closed
Market Cap: 30.8B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Cash Paid for Dividends

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Cash Paid for Dividends Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Cash Paid for Dividends
-ÂĄ907m
CAGR 3-Years
-11%
CAGR 5-Years
-15%
CAGR 10-Years
-12%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash Paid for Dividends
-ÂĄ294.7B
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
-8%
Daiichi Sankyo Co Ltd
TSE:4568
Cash Paid for Dividends
-ÂĄ95.8B
CAGR 3-Years
-22%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Cash Paid for Dividends
-ÂĄ66.8B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash Paid for Dividends
-ÂĄ131.6B
CAGR 3-Years
-10%
CAGR 5-Years
-18%
CAGR 10-Years
-18%
Astellas Pharma Inc
TSE:4503
Cash Paid for Dividends
-ÂĄ125.5B
CAGR 3-Years
-17%
CAGR 5-Years
-12%
CAGR 10-Years
-8%
No Stocks Found

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
30.7B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
2 429.67 JPY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Daito Pharmaceutical Co Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-907m JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Cash Paid for Dividends amounts to -907m JPY.

What is Daito Pharmaceutical Co Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 10Y
-12%

Over the last year, the Cash Paid for Dividends growth was 3%. The average annual Cash Paid for Dividends growth rates for Daito Pharmaceutical Co Ltd have been -11% over the past three years , -15% over the past five years , and -12% over the past ten years .

Back to Top